Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03774732
Title PD-1 Inhibitors and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer (NIRVANA-LUNG)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors UNICANCER
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Pembrolizumab + Pemetrexed Disodium

Carboplatin + Paclitaxel + Pembrolizumab

Cisplatin + Pembrolizumab + Pemetrexed Disodium

Age Groups: senior | adult
Covered Countries FRA

Additional content available in CKB BOOST